Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venkatesh Atul Bhattaram

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Biopharmaceutics & Drug Disposition|February 12, 2004
Evaluation of pharmacokinetics, brain levels and protein binding of centpropazine in ratsVenkatesh Atul Bhattaram, Jyoti K Paliwal, Ram C Gupta
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 12, 2002
Pharmacokinetics and bioavailability of herbal medicinal productsVenkatesh Atul Bhattaram, Ulrike Graefe, Claudia Kohlert, et al.
The AAPS Journal|June 13, 2009
Endpoints and analyses to discern disease-modifying drug effects in early Parkinson's diseaseVenkatesh Atul Bhattaram, Ohidul Siddiqui, Leonard P Kapcala, et al.
Journal of Clinical Pharmacology|June 10, 2014
Population pharmacokinetics of cilengitide in adult and pediatric cancer patients from a nonlinear mixed-effects analysisMichael Zühlsdorf, Venkatesh Atul Bhattaram, Marco Campioni, et al.
Journal of Clinical Pharmacology|May 20, 2005
Population pharmacokinetics of eniporide and its metabolite in healthy subjects and patients with acute myocardial infarctionVenkatesh Atul Bhattaram, Nelamangala V Nagaraja, Tanja Peters, et al.
American Journal of Therapeutics|July 26, 2005
Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense?Ehab S el-Desoky, Rajanikanth Madabushi, Salah el-Din A Amry, et al.
Clinical and Translational Science|May 5, 2026
Optimizing Oligonucleotide Therapeutics: A Model-Informed Drug Development PerspectiveYe Yuan, Vishnu Sharma, Venkatesh Atul Bhattaram, et al.
Journal of Clinical Pharmacology|March 1, 2024
Application of Model-Informed Drug Development in Dose Selection and Optimization for siRNA TherapiesYe Yuan, Liang Li, Justin Earp, et al.
Journal of Clinical Pharmacology|August 9, 2024
Driving Efficiency: Leveraging Model-Informed Approaches in 505(b)(2) Regulatory ActionsVishnu Dutt Sharma, Venkatesh Atul Bhattaram, Kevin Krudys, et al.
Journal of Clinical Pharmacology|December 3, 2022
Model-Informed Approach Supporting Drug Development and Regulatory Evaluation for Rare DiseasesRuo-Jing Li, Lian Ma, Fang Li, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biopharmaceutics & Drug Disposition|February 12, 2004
Evaluation of pharmacokinetics, brain levels and protein binding of centpropazine in ratsVenkatesh Atul Bhattaram, Jyoti K Paliwal, Ram C Gupta
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 12, 2002
Pharmacokinetics and bioavailability of herbal medicinal productsVenkatesh Atul Bhattaram, Ulrike Graefe, Claudia Kohlert, et al.
The AAPS Journal|June 13, 2009
Endpoints and analyses to discern disease-modifying drug effects in early Parkinson's diseaseVenkatesh Atul Bhattaram, Ohidul Siddiqui, Leonard P Kapcala, et al.
Journal of Clinical Pharmacology|June 10, 2014
Population pharmacokinetics of cilengitide in adult and pediatric cancer patients from a nonlinear mixed-effects analysisMichael Zühlsdorf, Venkatesh Atul Bhattaram, Marco Campioni, et al.
Journal of Clinical Pharmacology|May 20, 2005
Population pharmacokinetics of eniporide and its metabolite in healthy subjects and patients with acute myocardial infarctionVenkatesh Atul Bhattaram, Nelamangala V Nagaraja, Tanja Peters, et al.
American Journal of Therapeutics|July 26, 2005
Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense?Ehab S el-Desoky, Rajanikanth Madabushi, Salah el-Din A Amry, et al.
Clinical and Translational Science|May 5, 2026
Optimizing Oligonucleotide Therapeutics: A Model-Informed Drug Development PerspectiveYe Yuan, Vishnu Sharma, Venkatesh Atul Bhattaram, et al.
Journal of Clinical Pharmacology|March 1, 2024
Application of Model-Informed Drug Development in Dose Selection and Optimization for siRNA TherapiesYe Yuan, Liang Li, Justin Earp, et al.
Journal of Clinical Pharmacology|August 9, 2024
Driving Efficiency: Leveraging Model-Informed Approaches in 505(b)(2) Regulatory ActionsVishnu Dutt Sharma, Venkatesh Atul Bhattaram, Kevin Krudys, et al.
Journal of Clinical Pharmacology|December 3, 2022
Model-Informed Approach Supporting Drug Development and Regulatory Evaluation for Rare DiseasesRuo-Jing Li, Lian Ma, Fang Li, et al.
Pageof 2